HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis.

Abstract
A 50-year-old woman was admitted because of high fever and fatigue. Proteinuria, hematuria, and elevated BUN (47.8 mg/dl) and creatinine (3.4 mg/dl) suggested rapidly progressive glomerulonephritis. The serological study revealed all negative results for rheumatoid factor, antinuclear antibody, serum cryoglobulins, MPO-ANCA, PR3-ANCA, and anti-streptolysin O. Antiglomerular basement membrane (GBM) antibody, as assessed by ELISA, was 11 EU (normal, <10). Kidney biopsy on the eighth hospital day demonstrated pauci-immune-type crescentic glomerulonephritis without ANCA. Methylprednisolone pulse therapy (500 mg/day, 3 days) and 45 mg/day prednisolone orally were started. At 3 weeks after kidney biopsy, the anti-GBM antibody value increased from 11 EU/ml to 116 EU/ml, and MPO and PR3-ANCA were still negative. HLA type was DR8 and DR 15(2), with a genotype of HLA-DRB1*08021 and HLA-DRB1*15011. The present case suggests that HLA-DR15 plays an important role on antibody production against alpha 3(IV) NC1 autoantigen after severe nephritis or tissue damage.
AuthorsWataru Kitagawa, Naoto Miura, Harutaka Yamada, Kazuhiro Nishikawa, Arao Futenma, Hirokazu Imai
JournalClinical and experimental nephrology (Clin Exp Nephrol) Vol. 9 Issue 1 Pg. 69-73 (Mar 2005) ISSN: 1342-1751 [Print] Japan
PMID15830277 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies
  • Autoantibodies
  • Glucocorticoids
  • HLA-DR Antigens
  • HLA-DR Serological Subtypes
  • HLA-DR15 antigen
  • antiglomerular basement membrane antibody
  • Prednisolone
  • Methylprednisolone
Topics
  • Anti-Inflammatory Agents (adverse effects, therapeutic use)
  • Antibodies (blood)
  • Autoantibodies
  • Drug Therapy, Combination
  • Female
  • Glomerulonephritis (diagnostic imaging, drug therapy, immunology, pathology)
  • Glucocorticoids (adverse effects, therapeutic use)
  • HLA-DR Antigens (blood)
  • HLA-DR Serological Subtypes
  • Humans
  • Methylprednisolone (therapeutic use)
  • Middle Aged
  • Prednisolone (adverse effects, therapeutic use)
  • Radionuclide Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: